Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

5,995 public trials 1,209 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Recruiting

Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV Melanoma

NCT05428007

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations
  • The Angeles Clinic at Cedars Sinai Los Angeles, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • NYU Langone Health New York, United States
View Trial Details
Recruiting

A Study of VRT106 for Injection in Patients With Recurrent/Progressive Glioblastoma

NCT07093814

Conditions
Astrocytoma, Glioblastoma, Glioma, +7 more
Locations
  • The First Affiliated Hospital of USTC Hefei, Anhui, China
  • Sanbo Brain Hospital Capital Medical University Beijing, Beijing Municipality, China
  • The Cancer Hospital Affiliated to Chongqing University Chongqing, Chongqing Municipality, China
  • Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China
View Trial Details

Related conditions